Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

On day one of the highly anticipated first meeting of the CDC's newly formed vaccine advisory committee, members debated the ...

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines.The FDA is expanding warnings on Pfizer and ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

As Covid cases decrease, experts are observing a resurgence of seasonal viruses including influenza and rhinovirus. This ...

WHO also reported that global COVID-19 deaths keep declining. The VDH is no longer reporting COVID fatalities and cases in ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...

Published in The Journal of Infectious Diseases, a University of Minnesota research team demonstrated that measuring SARS-CoV ...